Literature DB >> 11084070

Changing strategies in diagnosis and management of hilar cholangiocarcinoma.

J Figueras1, L Llado, C Valls, T Serrano, E Ramos, J Fabregat, A Rafecas, J Torras, E Jaurrieta.   

Abstract

Hilar cholangiocarcinoma is one of the most difficult tumors to stage and treat. This study aims to evaluate (1) the best diagnostic imaging, (2) the usefulness of preoperative biliary drainage, (3) the resectability rate, and (4) the results of palliative treatments and surgical resection. Seventy-six patients with hilar cholangiocarcinoma with a mean age of 64 +/- 11 years were treated at our institution from 1989 to 1999. Patients were studied preoperatively using ultrasound, computed tomography (CT), and percutaneous cholangiography or magnetic resonance cholangiography. Forty-eight patients (63%) underwent palliative treatment. Twenty-eight patients underwent surgical curative therapy; 20 resections and 8 orthotopic liver transplantations (OLTs). Percutaneous transhepatic cholangiography was performed in 18 of 28 patients (64%), and magnetic resonance cholangiography in 5 patients; both methods were equally effective in establishing tumoral invasion of the biliary ducts. Five patients did not undergo either diagnostic modality. Excluding the patients who underwent OLT, no significant differences were found in surgical mortality (1 v 2 patients) or postoperative morbidity (100% v 66%) for patients with and without preoperative biliary drainage. The postoperative mortality rate was 11% (3 of 28 patients). The overall resectability rate was 37%. Mean survival in the surgical and palliative groups was 35 and 6 months, respectively (P <.0001). Patients who underwent OLT had a better 5-year survival rate than those treated by tumor resection (36% v 21%; P =.02). Combined chemotherapy and radiotherapy apparently did not provide a significant survival benefit. Helical CT and magnetic resonance cholangiography are useful techniques to delineate tumor extent and rule out vascular invasion and lymph node or liver metastases. No clear conclusions regarding preoperative drainage can be drawn from this study. A high resectability rate (37%) is feasible with major hepatectomy.

Entities:  

Mesh:

Year:  2000        PMID: 11084070     DOI: 10.1053/jlts.2000.18507

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  42 in total

1.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.

Authors:  S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 2.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

Review 3.  CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.

Authors:  T Hyodo; S Kumano; F Kushihata; M Okada; M Hirata; T Tsuda; Y Takada; T Mochizuki; T Murakami
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

Review 4.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

5.  Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.

Authors:  Zhi-Hua Liu; Yan-Ping He; Yukun Zhou; Peng Zhang; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2010-01-29       Impact factor: 2.316

Review 6.  Cholangiocarcinoma and its management.

Authors:  S A Khan; A Miras; M Pelling; S D Taylor-Robinson
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

7.  Outcome of surgical treatment of hilar cholangiocarcinoma.

Authors:  Kazuhiro Otani; Kazuo Chijiiwa; Masahiro Kai; Jiro Ohuchida; Motoaki Nagano; Kazuyo Tsuchiya; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-12-18       Impact factor: 3.452

8.  Preoperative biliary drainage before resection for cholangiocarcinoma (Pro).

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 9.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

10.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.